Replies to post #67198 on NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

I expect Abzena can do gene expression profiling at the time of GBM diagnosis.
Thus identifying mesenchymal subtype.

[Know-Fear]

Have not had much time to post. I'll try not to read too much into it as well.....along that vein would I be correct in assuming NW investment in Abzena predates his investment in NWBO?

More good stuff, thanks.